Sign up for email alert when new content gets added: Sign up
Ofonime M Ogba, Lydia N Abia-Bassey and James Epoke
University of Calabar, Nigeria
Posters & Accepted Abstracts: Microbiol Biotechnol Rep
Introduction: Zygomycosis is a rare infection but the incidence is on the rise as a result of increased use of chemotherapy and steroids among immunosuppressed patients. It is an invasive angiotropic infection with fungi of the Mucorales order, which includes Mucor species, Rhizopus species, Rhizomucor species, and multiple others. The second most common form of the infection is pulmonary. Materials & Methods: HIV-positive subjects with respiratory symptoms were enrolled for the study. Subjects selection was based on HIV screening and the ability to produce sputum. A structured questionnaire was administered to all the subjects after obtaining their informed consent for demographic data. Ethical approval was obtained from the ethical research committee, UCTH, Calabar, Nigeria. Blood samples were obtained for CD4 count determination to ascertain the immune status of the patients. Sputum samples produced early in the morning were obtained twice from the subjects and subjected to macroscopy, microscopy and culture. The immune status of the subjects was assessed by CD4 count levels. Identification to the species complex level was performed by macroscopic and microscopic morphology. Results: Rhyzopus arrhyzus 50.0% and Litchthenia species 50% were the only Mucorales encountered among subjects in this study. 3.0% pulmonary zygomycosis prevalence was recorded in the study. Subjects with Rhizopus arrhyzus infection presented hemoptysis and cough while those with Absidia infection presented with variable symptoms including; cough, chest pain, sinusitis and fever. The mean CD4 counts of subjects with and without zygomycosis were 123.0�?±136.2 351.3�?±254.3 respectively. There was a statistically significant effect of zygomycosis on the CD4 counts of subjects (t=2.18, p=0.02). Conclusion: This study reveals that pulmonary zygomycosi is a health problem among HIV/AIDS patients in our locality. The immune status may have been influenced by the infection.
